Yuting Zhang1, Seo Hyon Baik. 1. Department of Health Policy and Management, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA, ytzhang@pitt.edu.
Abstract
BACKGROUND: Recent and national data on adherence to heart failure drugs are limited, particularly among the disabled and some small minority groups, such as Native Americans and Hispanics. OBJECTIVE: We compare medication adherence among Medicare patients with heart failure, by disability status, race/ethnicity, and income. DESIGN: Observational study. SETTING: US Medicare Parts A, B, and D data, 5% random sample, 2007-2009. PARTICIPANTS: 149,893 elderly Medicare beneficiaries and 21,204 disabled non-elderly beneficiaries. MAIN MEASURES: We examined 5% of Medicare fee-for-service beneficiaries with heart failure in 2007-2009. The main outcome was 1-year adherence to one of three therapeutic classes: β-blockers, diuretics, and angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin II receptor blockers (ARBs). Adherence was defined as having prescriptions in possession for ≥ 75% of days. KEY RESULTS: Among aged beneficiaries, 1-year adherences to at least one heart failure drug were 63%, 57%, 53%, 50%, and 52% for Whites, Asians, Hispanics, Native Americans and Blacks, respectively; among the disabled, 1-year adherence was worse for each group: 57%, 53%, 48%, 44% and 43% respectively. The racial/ethnic difference persisted after adjustment for age, gender, income, drug coverage, location and health status. Patterns of adherence were similar among beneficiaries on all three therapeutic classes. Among beneficiaries with close-to-full drug coverage, minorities were still less likely to adhere relative to Whites, OR = 0.61 (95% CI 0.58-0.64) for Hispanics, OR = 0.59 (95% CI 0.57-0.62) for Blacks and OR = 0.57 (95% CI 0.47-0.68) for Native Americans. CONCLUSION: After the implementation of Medicare Part D, adherence to heart failure drugs remains problematic, especially among disabled and minority beneficiaries, including Native Americans, Blacks, and Hispanics. Even among those with close-to-full drug coverage, racial differences remain, suggesting that policies simply relying on cost reduction cannot eliminate racial differences.
RCT Entities:
BACKGROUND: Recent and national data on adherence to heart failure drugs are limited, particularly among the disabled and some small minority groups, such as Native Americans and Hispanics. OBJECTIVE: We compare medication adherence among Medicare patients with heart failure, by disability status, race/ethnicity, and income. DESIGN: Observational study. SETTING: US Medicare Parts A, B, and D data, 5% random sample, 2007-2009. PARTICIPANTS: 149,893 elderly Medicare beneficiaries and 21,204 disabled non-elderly beneficiaries. MAIN MEASURES: We examined 5% of Medicare fee-for-service beneficiaries with heart failure in 2007-2009. The main outcome was 1-year adherence to one of three therapeutic classes: β-blockers, diuretics, and angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin II receptor blockers (ARBs). Adherence was defined as having prescriptions in possession for ≥ 75% of days. KEY RESULTS: Among aged beneficiaries, 1-year adherences to at least one heart failure drug were 63%, 57%, 53%, 50%, and 52% for Whites, Asians, Hispanics, Native Americans and Blacks, respectively; among the disabled, 1-year adherence was worse for each group: 57%, 53%, 48%, 44% and 43% respectively. The racial/ethnic difference persisted after adjustment for age, gender, income, drug coverage, location and health status. Patterns of adherence were similar among beneficiaries on all three therapeutic classes. Among beneficiaries with close-to-full drug coverage, minorities were still less likely to adhere relative to Whites, OR = 0.61 (95% CI 0.58-0.64) for Hispanics, OR = 0.59 (95% CI 0.57-0.62) for Blacks and OR = 0.57 (95% CI 0.47-0.68) for Native Americans. CONCLUSION: After the implementation of Medicare Part D, adherence to heart failure drugs remains problematic, especially among disabled and minority beneficiaries, including Native Americans, Blacks, and Hispanics. Even among those with close-to-full drug coverage, racial differences remain, suggesting that policies simply relying on cost reduction cannot eliminate racial differences.
Authors: L Kristin Newby; Nancy M Allen LaPointe; Anita Y Chen; Judith M Kramer; Bradley G Hammill; Elizabeth R DeLong; Lawrence H Muhlbaier; Robert M Califf Journal: Circulation Date: 2006-01-09 Impact factor: 29.690
Authors: Patricia Neuman; Michelle Kitchman Strollo; Stuart Guterman; William H Rogers; Angela Li; Angie Mae C Rodday; Dana Gelb Safran Journal: Health Aff (Millwood) Date: 2007-08-21 Impact factor: 6.301
Authors: Mariell Jessup; William T Abraham; Donald E Casey; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Marvin A Konstam; Donna M Mancini; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy Journal: Circulation Date: 2009-03-26 Impact factor: 29.690
Authors: Yuting Zhang; Judith R Lave; Julie M Donohue; Michael A Fischer; Michael E Chernew; Joseph P Newhouse Journal: Med Care Date: 2010-05 Impact factor: 2.983
Authors: Harindra C Wijeysundera; Márcio Machado; Farah Farahati; Xuesong Wang; William Witteman; Gabrielle van der Velde; Jack V Tu; Douglas S Lee; Shaun G Goodman; Robert Petrella; Martin O'Flaherty; Murray Krahn; Simon Capewell Journal: JAMA Date: 2010-05-12 Impact factor: 56.272
Authors: Yuting Zhang; Julie M Donohue; Judith R Lave; Gerald O'Donnell; Joseph P Newhouse Journal: N Engl J Med Date: 2009-07-02 Impact factor: 91.245
Authors: Kevin T Stroupe; Evgenia Y Teal; Michael Weiner; Irmina Gradus-Pizlo; D Craig Brater; Michael D Murray Journal: Am J Med Date: 2004-04-01 Impact factor: 4.965
Authors: Sunil Kripalani; Kathryn Goggins; Sam Nwosu; Jonathan Schildcrout; Amanda S Mixon; Candace McNaughton; Amanda M McDougald Scott; Kenneth A Wallston Journal: J Health Commun Date: 2015
Authors: JoEllen Jarrett Jamison; Junling Wang; Satya Surbhi; Samantha Adams; David Solomon; Kenneth C Hohmeier; Sharon McDonough; James C Eoff Journal: Divers Equal Health Care Date: 2016-08-23
Authors: Carla A Sueta; Jo E Rodgers; Patricia P Chang; Lei Zhou; Emily M Thudium; Anna M Kucharska-Newton; Sally C Stearns Journal: Am J Cardiol Date: 2015-05-08 Impact factor: 2.778
Authors: Keith C Ferdinand; Fortunato Fred Senatore; Helene Clayton-Jeter; Dennis R Cryer; John C Lewin; Samar A Nasser; Mona Fiuzat; Robert M Califf Journal: J Am Coll Cardiol Date: 2017-01-31 Impact factor: 24.094